A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
- Status
- COMPLETED
- Phase
- PHASE2
Exjade-Early-Trial
- Status
- TERMINATED
- Phase
- PHASE2
Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.
- Status
- COMPLETED
- Phase
- PHASE4
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
- Status
- TERMINATED
- Phase
- PHASE2
A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
- Status
- COMPLETED
- Phase
- PHASE2
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Symptom Burden in Chronic Myeloid Leukemia (CML)
- Status
- UNKNOWN
- Phase
- N/A
A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic
- Status
- TERMINATED
- Phase
- NA
Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)
- Status
- COMPLETED
- Phase
- PHASE4
A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
- Status
- COMPLETED
- Phase
- PHASE4
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
- Status
- TERMINATED
- Phase
- PHASE3
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
- Status
- TERMINATED
- Phase
- PHASE3
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE3
LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE2